Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease.

Leclair-Visonneau L, Clairembault T, Volteau C, Chapelet G, Le Dily S, Vavasseur F, Coron E, Préterre C, Neunlist M, Péréon Y, Derkinderen P.

Parkinsonism Relat Disord. 2018 Sep 18. pii: S1353-8020(18)30409-7. doi: 10.1016/j.parkreldis.2018.09.021. [Epub ahead of print]

PMID:
30262379
2.

REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease.

Leclair-Visonneau L, Clairembault T, Coron E, Le Dily S, Vavasseur F, Dalichampt M, Péréon Y, Neunlist M, Derkinderen P.

Neurology. 2017 Oct 10;89(15):1612-1618. doi: 10.1212/WNL.0000000000004496. Epub 2017 Sep 8.

PMID:
28887374
3.

Structural alterations of the intestinal epithelial barrier in Parkinson's disease.

Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, Heymann MF, Neunlist M, Derkinderen P.

Acta Neuropathol Commun. 2015 Mar 10;3:12. doi: 10.1186/s40478-015-0196-0.

4.

Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole.

Belhocine K, Vavasseur F, Volteau C, Flet L, Touchefeu Y, Bruley des Varannes S.

BMC Gastroenterol. 2014 Jul 15;14:128. doi: 10.1186/1471-230X-14-128.

5.

Analysis of colonic alpha-synuclein pathology in multiple system atrophy.

Pouclet H, Lebouvier T, Coron E, Rouaud T, Flamant M, Toulgoat F, Roy M, Vavasseur F, Bruley des Varannes S, Neunlist M, Derkinderen P.

Parkinsonism Relat Disord. 2012 Aug;18(7):893-5. doi: 10.1016/j.parkreldis.2012.04.020. Epub 2012 May 3.

PMID:
22560049
6.

Oral citrulline does not affect whole body protein metabolism in healthy human volunteers: results of a prospective, randomized, double-blind, cross-over study.

Thibault R, Flet L, Vavasseur F, Lemerle M, Ferchaud-Roucher V, Picot D, Darmaun D.

Clin Nutr. 2011 Dec;30(6):807-11. doi: 10.1016/j.clnu.2011.06.005. Epub 2011 Jul 5.

PMID:
21733603
7.

Colonic neuropathology is independent of olfactory dysfunction in Parkinson's disease.

Lebouvier T, Pouclet H, Coron E, Drouard A, N'Guyen JM, Roy M, Vavasseur F, Bruley des Varannes S, Damier P, Neunlist M, Derkinderen P, Rouaud T.

J Parkinsons Dis. 2011;1(4):389-94. doi: 10.3233/JPD-2011-11061.

PMID:
23939345
8.

Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting.

des Varannes SB, Sacher-Huvelin S, Vavasseur F, Masliah C, Le Rhun M, Aygalenq P, Bonnot-Marlier S, Lequeux Y, Galmiche JP.

World J Gastroenterol. 2006 Apr 28;12(16):2569-73.

9.

A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers.

Galmiche JP, Sacher-Huvelin S, Bruley des Varannes S, Vavasseur F, Taccoen A, Fiorentini P, Homerin M.

Aliment Pharmacol Ther. 2005 Mar 1;21(5):575-82.

10.

Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers.

Galmiche JP, Bruley Des Varannes S, Ducrotté P, Sacher-Huvelin S, Vavasseur F, Taccoen A, Fiorentini P, Homerin M.

Aliment Pharmacol Ther. 2004 Mar 15;19(6):655-62.

11.
12.

Assessment of caspase activity as a possible prognostic factor in acute myeloid leukaemia.

Oliver L, Vavasseur F, Mahé B, Perrin P, Harousseau JL, Meflah K, Vallette FM.

Br J Haematol. 2002 Aug;118(2):434-7.

PMID:
12139728
13.

Oxygen consumption and expression of the adenine nucleotide translocator in cells lacking mitochondrial DNA.

Loiseau D, Chevrollier A, Douay O, Vavasseur F, Renier G, Reynier P, Malthièry Y, Stepien G.

Exp Cell Res. 2002 Aug 1;278(1):12-8.

PMID:
12126953
14.

Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.

Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L.

Leukemia. 2001 Sep;15(9):1377-87.

PMID:
11516098
15.

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer.

Douillard JY, Bennouna J, Vavasseur F, Deporte-Fety R, Thomare P, Giacalone F, Meflah K.

Cancer Immunol Immunother. 2000 Apr;49(1):56-61.

PMID:
10782866
17.

An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.

Perrin P, Cassagnau E, Burg C, Patry Y, Vavasseur F, Harb J, Le Pendu J, Douillard JY, Galmiche JP, Bornet F, et al.

Gastroenterology. 1994 Dec;107(6):1697-708.

PMID:
7958681
18.

O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer.

Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I.

Eur J Biochem. 1994 Jun 1;222(2):415-24.

19.

[Treatment with butyrate/IL-2 combination in peritoneal carcinomatosis of colonic origin].

Perrin P, Burg C, Vavasseur F, Galmiche JP, Bornet F, Meflah K.

C R Acad Sci III. 1993 Jun;316(6):611-4. French.

PMID:
8019883
20.

Expression of alkaline phosphatase in murine lymphoma cells.

Harb J, Vavasseur F, Chadéneau C, Denis M, Meflah K.

Biochem Biophys Res Commun. 1991 May 31;177(1):125-33.

PMID:
1645955

Supplemental Content

Loading ...
Support Center